Pharmacogenomics: Using DNA to Save Lives
Economics
Due to the lack of personalization in the health care industry, the Pharmacogenomics industry and the DNA and genetic industries are growing and continuing to make great advances. Most of these advancements are expensive but with the continuing advancements, DNA testing could be available for the average person and more affordable. Depending on what you are seeking to research and its specialty, i.e. ancestory, genetics, medicine sensitivity, carrier gene traits etc, the price will range in value.
This graph represents how size (in the amount of a human genome, or size of a human body) affects price. This graph rapidly decreases as time goes on. One difference from the graph to the right is that this graph starts at a higher price point per organism while the graph to the left does not. This graph could also represent that using resources for one person could cause an increased price point until more information and is available for the public.
This graph represents how quantity (one million of DNA being tested) effects price. Similar to the graph on the left, both decrease over time as technology improves. Interestingly, this graph has a significant price difference to the graph on the right and is cheaper possibly due to the amount of items that are being tested instead of focusing on one individual.
